NCT06239740

Brief Summary

The goal of this pilot Study and Randomized Controlled Trial is to investigate the impact of electroacupuncture on cognitive function, quality of life (QoL), and depression severity in patients with major depressive disorder (MDD). The main question\[s\] it aims to answer are:

  • Primary : electroacupuncture has the potential to treat subjective cognitive complaints and cognitive impairment in MDD outpatients
  • Secondary : electroacupuncture has the potential to treat depressive in MDD outpatients The 60 participants will randomly be assigned to either the treatment group or the control group in a 1:1 ratio. The treatment group will undergo electroacupuncture (EA), while the control group will receive sham acupuncture within 10 weeks period. Both groups will receive antidepressants with adjunctive medication (i.e., benzodiazepines, tricyclics, or antipsychotics) as the standard treatment. All participants will be assessed for executive functions and memory using specific cognitive tests, including the Trail Making Test B (TMT-B), Stroop Color and Word Test (SCWT), category delayed recall in the Alzheimer's Disease Assessment Scale-Cognitive Subscale (ADAS-Cog), and subjective reports of concern regarding concentration, memory, problem-solving, learning, communication, and quality of life (QoL) concerns using the WHO Disability Assessment Schedule (WHODAS 2.0; sections D1.1-1.6 and H1-3), and depressive symptoms were assessed using the Thai-PHQ-9.

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
60

participants targeted

Target at P25-P50 for not_applicable

Timeline
Completed

Started Dec 2022

Shorter than P25 for not_applicable

Geographic Reach
1 country

1 active site

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

December 24, 2022

Completed
1 month until next milestone

Primary Completion

Last participant's last visit for primary outcome

January 24, 2023

Completed
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

January 24, 2023

Completed
12 months until next milestone

First Submitted

Initial submission to the registry

January 12, 2024

Completed
21 days until next milestone

First Posted

Study publicly available on registry

February 2, 2024

Completed
Last Updated

February 2, 2024

Status Verified

January 1, 2024

Enrollment Period

1 month

First QC Date

January 12, 2024

Last Update Submit

January 25, 2024

Conditions

Keywords

ElectroacupunctureDepressionCognitionHumansPilotRandomized Controlled Trial

Outcome Measures

Primary Outcomes (4)

  • Trail making test B (TMT-B)

    The TMT- B is scored based on the time (in seconds) it takes to complete the test, including corrections for errors prompted by the examiner. A shorter time implies better performance.

    Pre-intervention at the beginning point (T0) and the endpoint will be the 10th week (T10)

  • The Stroop Color and Word Test (SCWT)

    SCWT used to assess the ability to inhibit cognitive interference that occurs when the processing of a specific stimulus feature impedes the simultaneous processing of a second stimulus attribute."Score" refers to the number of words achieved, and a higher number of words indicates a better score.

    Pre-intervention at the beginning point (T0) and the endpoint will be the 10th week (T10)

  • ADAS-cog category delayed recall

    ADAS-cog category delayed recall is used to assess memory. The score reflects the number of words that can be remembered. The more words remembered, the better the score.

    Pre-intervention at the beginning point (T0) and the endpoint will be the 10th week (T10)

  • Subjective cognitive complaint

    WHODAS 2.0; sections D1.1-1.6 and H1-3, which is a questionnaire asking about the number of days in the past 30 days when participants experienced difficulties with attention, understanding, and initiating conversation. "Score" is the rating of the number of days with issues, and a decrease in score indicates improvement or a better outcome.

    Pre-intervention at the beginning point (T0) and the endpoint will be the 10th week (T10)

Secondary Outcomes (1)

  • Thai Patient Health Questionnaire (PHQ-9)

    Pre-intervention at the beginning point (T0) and the endpoint will be the 10th week (T10)

Study Arms (2)

Electroacupuncture group

EXPERIMENTAL

In the electroacupuncture group (EG), participants received acupuncture at 10 scalp points (Baihui \[GV20\], Ex-hn 1, 3 points of intelligence \[Shenting \[GV24\], Benshen \[GB13\] on both sides, Touwei \[ST8\] on both sides). Electroacupuncture was applied for 20 minutes at Benshen \[GB13\] and Touwei \[ST8\] on both sides. They also received acupuncture at Tai chong \[LV3\], Tai Yuan \[LU9\], and Tai Xi \[KI3\] on both sides, as shown in picture 1. Acupuncture sessions were weekly for 10 weeks.

Procedure: Electroacupuncture group

Sham acupuncture

SHAM COMPARATOR

In the sham acupuncture control group (CG), participants received acupress or a brief needle insertion at He gu on both hands during the first and 10th weeks, marking the endpoint of the study

Procedure: Sham acupuncture

Interventions

The acupuncture needle was placed on the scalp at a Chinese traditional acupuncture point. Subsequently, a small electrode was attached to the needle. A minor amount of electricity runs through the electrode, producing a slight vibration or soft hum during the treatment.

Also known as: electroacupuncture
Electroacupuncture group

participants received acupress or a brief needle insertion at He gu on both hands during the first and 10th weeks, marking the endpoint of the study

Sham acupuncture

Eligibility Criteria

Age18 Years - 55 Years
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64)

You may qualify if:

  • aged between 18 and 55 years
  • MDD diagnosed according to the DSM-5 or DSM-IV-TR criteria,
  • low suicidal risk
  • receiving treatment with antidepressants for at least 3 months from psychiatrists and psychiatric residents.
  • Subjective cognitive symptoms from the screening using the Thai version of the Patient Health Questionnaire (Thai-PHQ-9).

You may not qualify if:

  • severe cognitive deficits from traumatic brain injury, delirium, neurodevelopmental disorders, or intellectual disability;
  • neurological disorders such as stroke, Parkinson's disease, epilepsy, or other brain lesions;
  • severe medical conditions preventing lying down for 20 minutes;
  • recent electroconvulsive therapy (ECT) within the last 6 months;
  • Individuals with a pacemaker;
  • visual or hearing impairment that could not be corrected with eyeglasses or hearing aids;
  • severe MDD or scoring 20 points or more on the Thai-PHQ-9.

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Faculty of Medicine, Thammasat University

Khlong Luang, Changwat Pathum Thani, 12120, Thailand

Location

Related Publications (1)

  • Boontra Y, Thanetnit C, Phanasathit M. Effects of electroacupuncture on cognitive symptoms in major depressive disorder: a pilot study and randomized controlled trial. F1000Res. 2024 Dec 23;13:479. doi: 10.12688/f1000research.146897.4. eCollection 2024.

MeSH Terms

Conditions

Depressive Disorder, MajorCognitive DysfunctionDepression

Interventions

Electroacupuncture

Condition Hierarchy (Ancestors)

Depressive DisorderMood DisordersMental DisordersCognition DisordersNeurocognitive DisordersBehavioral SymptomsBehavior

Intervention Hierarchy (Ancestors)

Combined Modality TherapyTherapeuticsAcupuncture TherapyComplementary TherapiesElectric Stimulation TherapyPhysical Therapy ModalitiesRehabilitationTranscutaneous Electric Nerve StimulationAnalgesiaAnesthesia and AnalgesiaAnesthesia

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
TRIPLE
Who Masked
PARTICIPANT, CARE PROVIDER, OUTCOMES ASSESSOR
Masking Details
In the sham acupuncture control group (CG), participants received acupress or a brief needle insertion at He gu on both hands during the first and 10th weeks, marking the endpoint of the study.
Purpose
TREATMENT
Intervention Model
PARALLEL
Model Details: In the electroacupuncture group (EG), participants received acupuncture at 10 scalp points (Baihui \[GV20\], Ex-hn 1, 3 points of intelligence \[Shenting \[GV24\], Benshen \[GB13\] on both sides, Touwei \[ST8\] on both sides). Electroacupuncture was applied for 20 minutes at Benshen \[GB13\] and Touwei \[ST8\] on both sides. They also received acupuncture at Tai chong \[LV3\], Tai Yuan \[LU9\], and Tai Xi \[KI3\] on both sides, as shown in picture 1. Acupuncture sessions were weekly for 10 weeks. In the sham acupuncture control group (CG), participants received acupress or a brief needle insertion at He gu on both hands during the first and 10th weeks, marking the endpoint of the study.
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
Doctor of Medicine

Study Record Dates

First Submitted

January 12, 2024

First Posted

February 2, 2024

Study Start

December 24, 2022

Primary Completion

January 24, 2023

Study Completion

January 24, 2023

Last Updated

February 2, 2024

Record last verified: 2024-01

Data Sharing

IPD Sharing
Will share

The data set will be share on Zenodo

Shared Documents
STUDY PROTOCOL
Time Frame
January 15, 2024 and for 5 years (Jan 14, 2029)
Access Criteria
no limitation
More information

Available IPD Datasets

Study Protocol Access

Locations